Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|April 25, 2014
Pitfalls in genetic analysis of pheochromocytomas/paragangliomas-case reportLetizia Canu, Elena Rapizzi, Benedetta Zampetti, et al.
Endocrine-Related Cancer|September 11, 2023
Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotaneGiulia Cantini, Elena Niccolai, Letizia Canu, et al.
Oncotarget|October 15, 2017
New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancerFrancesca Salvianti, Letizia Canu, Giada Poli, et al.
Endocrine Pathology|March 23, 2023
Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical CarcinomaMichaela Luconi, Giulia Cantini, Rachel S van Leeuwaarde, et al.
The Journal of Liquid Biopsy|December 9, 2025
An innovative nuclear antigen-based approach for single-cell isolation of circulating tumor cells in adrenal cortical carcinomaGiulia Cantini, Francesca Salvianti, Roberta Armignacco, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2018
Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical CarcinomaGiada Poli, Carmen Ruggiero, Giulia Cantini, et al.
Medicina (Kaunas, Lithuania)|August 26, 2022
Novel Germline <i>PHD2</i> Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of PolycythemiaAldesia Provenzano, Massimiliano Chetta, Giuseppina De Filpo, et al.
Neuroendocrinology|January 26, 2017
The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated ParagangliomasLindsey Oudijk, Thomas Papathomas, Ronald de Krijger, et al.
Frontiers in Endocrinology|January 25, 2024
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapyLetizia Canu, Clotilde Sparano, Lara Naletto, et al.
Pageof 8